Legal Opinion
Nostrum Pharmaceuticals LLC v. FDA
Court of Appeals for the D.C. Circuit
Decided June 3, 2022No. 20-1525PublishedCited by 3 opinions
1Opinion of the Court
United States Court of Appeals FOR THE DISTRICT OF COLUMBIA CIRCUIT Submitted March 2, 2022 Decided June 3, 2022 No. 20-1525 NOSTRUM PHARMACEUTICALS, LLC, PETITIONER v. UNITED STATES FOOD AND DRUG ADMINISTRATION, RESPONDENT On Petition for Review of Orders of the Food and Drug Administration Shashank Upadhye was on the briefs for petitioner. Douglas B. Farquhar entered an appearance. Brian M. Boynton, Acting Assistant Attorney General at the time the brief was filed, U.S. Department of Justice, Scott McIntosh and Joshua Dos Santos, Attorneys, Daniel J. Barry, Acting General Counsel, U.S.…
2Cases cited5 opinions
- Bennett v. SpearSupreme Court of the United States · 1997
- Bellsouth Corp. v. Federal Communications CommissionCourt of Appeals for the D.C. Circuit · 1994
- Cal. Cmty. Against Toxics v. Envtl. Prot. AgencyCourt of Appeals for the D.C. Circuit · 2019
- MediNatura, Inc. v. FDACourt of Appeals for the D.C. Circuit · 2021
- Pharmaceutical Manufacturing Research Services, Inc. v. FDACourt of Appeals for the D.C. Circuit · 2020
3Cited by3 opinions
- An opinion was released in case 23-5200, Vanda Pharmaceuticals, Inc. v. FDACourt of Appeals for the D.C. Circuit · 2024
- Avadel Cns Pharmaceuticals, LLC v. BecerraDistrict Court, District of Columbia · 2022
- Sorrento Therapeutics, Inc. v. Anthony MackCourt of Chancery of Delaware · 2023